Healthways (HWAY): Raising PT By 70% - Piper Jaffray

Piper Jaffray analyst, Sean Wieland reiterated his Overweight rating on Healthways (NASDAQ: HWAY) and increased the PT to $25.50 from $15 after Healthways completed the sale of its pop health business, and reported the continuing operations of the remaining Networks Solutions business. Based on the increased margin profile, and completely different business model, the analyst is changing his price target methodology to more closely reflect its peers.

HWAY will provide more details about its new growth strategy at its Analyst Day on 8/11,

For an analyst ratings summary and ratings history on Healthways click here. For more ratings news on Healthways click here.

Shares of Healthways closed at $18.06 yesterday.

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• NetEase.com (NTES) PT Lowered to $143 at Macquarie
• Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy